NCT00485368View on ClinicalTrials.gov

Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

September 30, 2006

Conditions
Marfan Syndrome
Interventions
DRUG

Coversyl (perindopril)

Sponsors

Lead Sponsor

Bayside Health
All Listed Sponsors
collaborator

Baker Heart Research Institute

OTHER

collaborator

The Alfred

OTHER

lead

Bayside Health

OTHER_GOV